The treatment of hemorrhagic cystitis first involves discontinuation of the offending agent. Agents such as anticoagulants and inhibitors of platelet function should also be discontinued. IV fluids should be aggressively administered to irrigate the bladder. Blood and platelet transfusions may be necessary to maintain normal hematologic values. Pain should be managed with opioid analgesics. Local intravesicular therapies may be necessary if hematuria does not resolve (Fig. 99-3).
A large-diameter, multihole urethral catheter should be inserted to facilitate saline lavage and evacuation of blood clots. Surgical removal of blood clots under anesthesia may be required if saline lavage is ineffective. Active bleeding from isolated areas may be cauterized with an electrode or laser. In severe cases that are unresponsive to local or systemic pharmacologic intervention, urinary diversion with percutaneous nephrostomy or surgical removal of the bladder may be required.
Table 99-12 ASCO Guidelines for the Use of Mesna With Ifosfamide and High-Dose Cyclophosphamide
Dosing Schedule for Menu
GlCfllCr (hjn ij/m /day
Standard dose eye lophospfiamide Hiqli-tViW cytlophOiphsnnKle Lbiirw rnnf transptanl '.■
Oiih lOWbol kjidi üjiiyttoíí c< ¡rsJjínkíegi/wi ÍOUIV lí mlnnies before "Wfc po 2 inri t Italic dilct iliiM of ilotifdmldc
Bolus. oí lolaldjilydoaoof ifosfamkio given W in ¡nf (einf nn i i mamKj t>eí<>e ¿no J ¿no e frjuii. aim m.ki of ikfif.sniKlr
IrifuyofK W96 eitofjIJjily ítOW íH JwfjiirtiíJíí ■givtn ?OW IVmlnum before and Oírtt by continuous infusion dmiog jpd fai 12-24Jioursarrci (.-ndof fcMdi
Lack of evidence far dosing tawever higher doses 1ut fcmgtT durillwi recommended b*scd on kHV^f'i I LIII1-lin iif IfosfMnidf likjh Uw of mesna is not routinely necessary Bolus- JCrtt erf C ytk>gyv>4CilwnkJe CfcWi? P/M
horns G, i b, and 9 ailer cyckjpfrospfriamide Infuyon 100% OI ¿ydüptyBjjhürnide düíí giw.fi Dytoniliniíous infusion imnii 24 hoois aitei cyclophosphamide
AujiUtiie in 400-iflg (jbioit
Peik uiiii.ify (hlot concentrations «lili oral rrKiiH is ut 3 S>ouit II fntlKrll rtjmlfi nilhin 2 htXlfiOf adminWijtioíi, nppeji fío*? ofíllyof W
FYnk urinary thiol oonctnLiatlons with IV
frtfjft) Ijjf 1 hour Compatible wiih tftftfamide iind i^tlüptraifihjmidíj ly V-ille jdmlnbualion Oi v/w^ilrnixixr in rlH' mine 15*1
ASdjÜ. American Society of Liintjl Uncofogy. Ficm 1W. .Ifi.
A number of local or systemic agents are utilized in the treatment of hemorrhagic cystitis.45 Local (direct instillation into the bladder), one-time administration of hemostatic agents such as alum, prostaglandins, silver nitrate, and formalin may be used; however general anesthesia is required, especially with formalin due to pain. Systemic agents including estrogens, vasopressin, and aminocaproic acid may be used in patients who are refractory to local therapy, although they introduce the risk of systemic side effects. These agents should be continued until bleeding stops.
Antispasmodic agents such as oxybutynin 5 mg by mouth 2 to 3 times daily may be used for bladder spasms. In patients with refractory pain, opioid analgesics should be titrated to adequate pain control.
Was this article helpful?
Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.